These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16375954)

  • 1. Pharmacotherapy and smoking cessation at a tobacco dependence clinic.
    Steinberg MB; Foulds J; Richardson DL; Burke MV; Shah P
    Prev Med; 2006 Feb; 42(2):114-9. PubMed ID: 16375954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies.
    Steinberg MB; Bover MT; Richardson DL; Schmelzer AC; Williams JM; Foulds J
    Drug Alcohol Depend; 2011 Mar; 114(1):77-81. PubMed ID: 20951511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
    Chatkin JM; Mariante de Abreu C; Haggsträm FM; Wagner MB; Fritscher CC
    Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of an intervention to facilitate recycling for relapsed smokers.
    Partin MR; An LC; Nelson DB; Nugent S; Snyder A; Fu SS; Willenbring ML; Joseph AM
    Am J Prev Med; 2006 Oct; 31(4):293-9. PubMed ID: 16979453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varenicline and bupropion sustained-release combination therapy for smoking cessation.
    Ebbert JO; Croghan IT; Sood A; Schroeder DR; Hays JT; Hurt RD
    Nicotine Tob Res; 2009 Mar; 11(3):234-9. PubMed ID: 19246427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
    Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
    Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation treatment in a real-life setting: the Greek experience.
    Rovina N; Nikoloutsou I; Dima E; Michailidou M; Roussos C; Gratziou C
    Ther Adv Respir Dis; 2007 Dec; 1(2):93-104. PubMed ID: 19124351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence.
    Hays JT; Leischow SJ; Lawrence D; Lee TC
    Nicotine Tob Res; 2010 Jun; 12(6):574-81. PubMed ID: 20457644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
    McCarthy DE; Piasecki TM; Lawrence DL; Jorenby DE; Shiffman S; Fiore MC; Baker TB
    Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tobacco cessation. Action-stage result as a predictor of successful long-term maintenance].
    Barrueco Ferrero M; Torrecilla García M; Hernández Mezquita MA; Jiménez Ruiz CA; Morales Sánchez A; Alonso Díaz A; Plaza Martín D
    Arch Bronconeumol; 2007 Mar; 43(3):136-42. PubMed ID: 17386189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waking at night to smoke as a marker for tobacco dependence: patient characteristics and relationship to treatment outcome.
    Bover MT; Foulds J; Steinberg MB; Richardson D; Marcella SW
    Int J Clin Pract; 2008 Feb; 62(2):182-90. PubMed ID: 18199277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year.
    Grassi MC; Enea D; Ferketich AK; Lu B; Nencini P
    Nicotine Tob Res; 2009 Sep; 11(9):1114-21. PubMed ID: 19654237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A smoking cessation intervention for the methadone-maintained.
    Stein MD; Weinstock MC; Herman DS; Anderson BJ; Anthony JL; Niaura R
    Addiction; 2006 Apr; 101(4):599-607. PubMed ID: 16548939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking cessation patterns in methadone-maintained smokers.
    Stein MD; Anderson BJ; Niaura R
    Nicotine Tob Res; 2007 Mar; 9(3):421-8. PubMed ID: 17365774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking status of Australian general practice patients and their attempts to quit.
    Doran CM; Valenti L; Robinson M; Britt H; Mattick RP
    Addict Behav; 2006 May; 31(5):758-66. PubMed ID: 16137834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion and cognitive-behavioral therapy for smoking cessation in women.
    Schmitz JM; Stotts AL; Mooney ME; Delaune KA; Moeller GF
    Nicotine Tob Res; 2007 Jun; 9(6):699-709. PubMed ID: 17558827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
    Becker KM; Rose JE; Albino AP
    Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences among smokers receiving interventions for tobacco dependence in a medical setting.
    Croghan IT; Ebbert JO; Hurt RD; Hays JT; Dale LC; Warner N; Schroeder DR
    Addict Behav; 2009 Jan; 34(1):61-7. PubMed ID: 18814974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.